glp-1 military Q&A: Understanding TRICARE coverage of weight loss medications overseas > TRICARE Newsroom > TRICARE News Q&A: TRICARE For Life Coverage

10

The Rebound-Risk Estimator is a behavioral nudge, not a medical predictor

As mentioned, GLP-1RAs are increasingly used in the treatment of T2MD owing to their following advantages: lowering of the levels of blood glucose, reducing body weight, improving the function of islet, and exerting potential cardiovascular benefits (206)

Beyond promising evidence on the potential for prevention, evidence for the effect of physical activity on improvement of cognitive function in people already living with dementia remains less clear

Top Benefits: Enhances weight loss beyond GLP-1 alone Improves insulin response and glucose stability Boosts overall metabolic performance Once-weekly injectable therapy that mimics the natural GLP-1 hormone to improve appetite control and metabolic efficiency

3.3.2 Considers and respects the opinions, creativity, values, beliefs and perspectives of others